Structure-based redesign of lysostaphin yields potent antistaphylococcal enzymes that evade immune cell surveillance

Staphylococcus aureus infections exert a tremendous burden on the health-care system, and the threat of drug-resistant strains continues to grow. The bacteriolytic enzyme lysostaphin is a potent antistaphylococcal agent with proven efficacy against both drug-sensitive and drug-resistant strains; how...

Descripción completa

Detalles Bibliográficos
Autores principales: Blazanovic, Kristina, Zhao, Hongliang, Choi, Yoonjoo, Li, Wen, Salvat, Regina S, Osipovitch, Daniel C, Fields, Jennifer, Moise, Leonard, Berwin, Brent L, Fiering, Steven N, Bailey-Kellogg, Chris, Griswold, Karl E
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2015
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4470366/
https://www.ncbi.nlm.nih.gov/pubmed/26151066
http://dx.doi.org/10.1038/mtm.2015.21

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4470366/
https://www.ncbi.nlm.nih.gov/pubmed/26151066
http://dx.doi.org/10.1038/mtm.2015.21

Ejemplares similares